Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05303532
Title Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab (ROSY-D)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Durvalumab

Age Groups: senior | adult
Covered Countries ITA | FRA | DEU | CAN


No variant requirements are available.